跳至主要内容
临床试验/CTRI/2019/07/020179
CTRI/2019/07/020179尚未招募2 期

A Randomized open label Clinical study to evaluate the efficacy and safety of Quista-DN health drink in diabetic and pre-diabetic individuals - Quista_D

The Himalaya Drug Company0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Both male and female subjects aged more than 18 years with FBS > 100 till 140 mg/dl and PPBS > 140 till 240 mg/dl or known Diabetic taking Oral hypoglycemic agents.
  • 2. Subjects who have not participated in similar kind of study in last 4 weeks.
  • 3. Individuals willing to sign informed consent and comply with the study procedure

排除标准

  • Women who are pregnant or nursing an infant or planning to conceive during the period of the study
  • Suffering from severe systemic and endocrinal disorders
  • Allergic to any ingredient in the formulation.

研究者

相似试验